The rapid and reversible phosphorylation of proteins catalyzed by protein kinases and protein phosphatases is a well recognized mechanism of regulation in cells. This bidirectional process is a highly flexible method of influencing cellular activity in response to a variety of incoming stimuli. A physiological role for protein phosphorylation was first identified about 50 years ago while investigating the regulation of glycogen metabolism (Fischer and Krebs 1955; Sutherland 1972) . In fact, many aspects of gene regulation; cell cycle control, transport, and secretion; actin remodeling; and cell adhesion are controlled by this mechanism (Krebs 1985; Hunter 1995; Pawson and Scott 1997; Cohen 2000; Goodman and Smolik 2000; Pawson and Nash 2000) . The utility of protein phosphorylation as the predominant form of covalent modification of proteins in vivo is exemplified by the finding that ∼30% of intracellular proteins are phosphoproteins (Hunter 1987) . Not surprisingly, the breakdown in signal transduction may be the cause or consequence of many diseases, including cancer, diabetes, arthritis, and Alzheimer's (Cohen 1999) .
Most signaling pathways are composed of common elements. The initial signal is transduced through a receptor at the plasma membrane (such as a G-protein coupled receptor, or a receptor tyrosine kinase or phosphatase), which results in activation of the receptor or the mobilization of receptor-associated proteins to generate some form of intracellular message. This signal is then directed throughout the cell either by the diffusion of a small soluble second messenger or the translocation of an activated enzyme. At a molecular level, phosphorylation mediates the regulation of enzymatic activities by causing allosteric conformational changes, or by directly enhancing or blocking access to enzyme catalytic sites (Johnson and Barford 1990; Barford et al. 1991; Johnson and O'Reilly 1996) . More recently it has been realized that an essential feature of signaling by protein phosphorylation is the modulation of protein-protein interactions. These are mediated by a growing number of protein interaction modules including WW, SH2, PTB, 14-3-3, WD-40, FHA, and FF domains that may associate with their binding partners in a phosphorylation-dependent manner (Cantley et al. 1991; Pawson and Gish 1992; Pawson 1995) . These protein-protein interactions generate molecular networks that drive intracellular signaling events. This fascinating topic was recently the subject of several excellent reviews (Burack and Shaw 2000; Hunter 2000; Jordan et al. 2000; Pawson and Nash 2000; Sudol and Hunter 2000) . In this article we emphasize how the subcellular location of protein kinases and phosphatases provides a means to restrict where and when phosphorylation events occur. In particular, we discuss the compartmentalization of the cAMP-dependent protein kinase (protein kinase A; PKA) through its association with A-kinase anchoring proteins (AKAPs).
cAMP-dependent signaling mechanisms
The second messenger cAMP was identified in 1957 as a factor that stimulates glycogen phosphorylase (Rall et al. 1957; Rall and Sutherland 1958) . However, this discovery as well as the development of the second messenger concept was not fully appreciated until a cAMP-dependent protein kinase was characterized over a decade later (Walsh et al. 1968) . Ever since this initial discovery, an intense global research effort has elucidated many molecular and cellular actions of cAMP. Engagement of transmembrane receptors and the recruitment of intermediary G proteins activate adenylyl cyclases on the inner face of the plasma membrane (Tang and Gilman 1992) . This cascade of events triggers an elevation of cAMP in certain intracellular compartments (Barsony and Marks 1990; Adams et al. 1991; Bacskai et al. 1993) . Although cAMP modulates the activities of molecules such as cyclic-nucleotide gated ion channels (Kaupp and Seifert 2002) , guanine nucleotide exchange factors (GEFs; de Rooij et al. 2000) , and cyclic-nucleotide phosphodiesterases (Houslay 2001) , the predominant intracellular receptor for this second messenger is the cAMPdependent protein kinase (PKA).
Most cell types express multiple cAMP-dependent protein kinase forms. The PKA holoenzyme is a tetramer composed of two catalytic (C) subunits that are held in an inactive state by association with a regulatory (R) subunit dimer (Corbin et al. 1973; Corbin and Keely 1977; Potter et al. 1978; Potter and Taylor 1979) . The catalytic subunits (C) are expressed from three different genes; C␣, C␤, and C␥, whereas the regulatory subunits (R) are expressed from four different genes; RI␣, RI␤, RII␣, and RII␤ (Lee et al. 1983; Scott et al. 1987; Chrivia et al. 1988) . The R subunit is a modular protein containing an NH 2 -terminal homo-dimerization domain, a pseudosubstrate/autophosphorylation site that serves as the principal site of contact for the C subunit, and two cAMPbinding sites. Binding of cAMP to the R subunits relieves the autoinhibitory contact, causing the C subunits to dissociate and allowing phosphorylation of substrates (Wang et al. 1991; Gibbs et al. 1992) . Two subtypes of the PKA holoenzyme can be formed. The type I PKA (composed of RI dimers) is thought to be predominantly cytoplasmic and is most highly expressed in the immune system, whereas type II PKA (composed of RII dimers) associates with specific cellular structures and organelles and is abundant in the heart and brain (Scott 1991) .
One remaining question in PKA signaling is how this "broad spectrum" kinase can be implicated in the specific regulation of so many physiological processes. This is compounded by evidence that multiple agonists that engage a ubiquitous cAMP synthesis pathway initiate specific PKA phosphorylation events (Livesey et al. 1982) . Accordingly, the mechanism by which PKA distinguishes between its substrates is a topic of intense investigation. This is particularly true in the brain, where PKA substrates such as ligand-gated and voltagegated ion channels are clustered together at synapses, yet changes in the phosphorylation state of either substrate cause distinct changes in synaptic plasticity (Brandon et al. 1995 (Brandon et al. , 1997 Malenka and Nicoll 1999; Kind and Neumann 2001; Malinow and Malenka 2002; Sheng and Kim 2002) . One explanation for this phenomenon is that compartment-specific pools of PKA are activated in close proximity to these channels. However, this can only occur if there is a means to selectively manipulate subcellular pools of cAMP. Accordingly, it has been proposed that a balance of adenylyl cyclase and phosphodiesterase activities leads to establishment of intracellular gradients of cAMP . Within these theoretical "nano-compartments", the activation state of PKA is believed to mirror the ebb and flow of second messenger levels (Beavo and Brunton 2002; Zaccolo and Pozzan 2002) . In order to maintain PKA at these sites, "organizing" proteins called AKAPs exist to restrict the diffusion of the kinase and place the enzyme close to certain substrates (Rubin 1994; Colledge and Scott 1999; Skalhegg and Tasken 2000; Kapiloff 2002; Smith and Scott 2002) . This review concentrates on the role of AKAPs as molecular mediators of PKA signaling specificity in the brain.
The AKAP model
The first AKAPs were identified as proteins that copurified with the type II PKA holoenzyme (Theurkauf and Vallee 1982; Bregman et al. 1989) . Neuronal proteins, such as MAP2 and p75 (now known as AKAP75) were initially designated "RII-binding proteins" on the basis of their ability to remain tightly associated with the type II R subunits during affinity purification on cAMPsepharose (Theurkauf and Vallee 1982; Bregman et al. 1989) . The development of a modified Western blot procedure called the RII-overlay led to the identification of additional AKAPs in the brain and most other tissues (Lohmann et al. 1984; Carr and Scott 1992) . This technique was subsequently adapted for use in an interaction cloning strategy where radiolabeled RII was used as a probe to screen cDNA expression libraries (Bregman et al. 1991; Carr et al. 1992a,b; Coghlan et al. 1994) . Using this and related techniques, upwards of 30 AKAPs have been identified (Colledge and Scott 1999; Bauman and Scott 2002) . Most AKAPs share three common properties ( Fig. 1): (1) an R subunit-binding sequence, (2) unique localization signals that target the PKA/AKAP complex to membranes, organelles, and subcellular environments, and (3) additional enzyme-binding sites that permit the formation of multiprotein signaling complexes. Each of these properties is discussed below.
Common PKA anchoring domains
Most AKAPs contain a recognizable sequence that forms a binding site for the R subunits. This motif was first identified in the human thyroid anchoring protein, AKAP-lbc, where a 24-residue peptide called Ht31 was generated that bound RII with nanomolar affinity (Carr et al. 1991 (Carr et al. , 1992a . The Ht31 sequence is predicted to form an amphipathic helix, and structural studies indicate that this region slots into a binding pocket formed by the N-terminal regions of each RII protomer (Newlon et al. 1997 (Newlon et al. , 1999 (Newlon et al. , 2001 . Cellular delivery of this peptide has become a standard means to delineate a role for AKAPs in the coordination of cAMP-responsive events by antagonizing PKA anchoring inside cells (Rosenmund et al. 1994; Lester et al. 1997; Vijayaraghavan et al. 1997; Feliciello et al. 2001; Moita et al. 2002; Tavalin et al. 2002) . A consensus PKA anchoring motif called "AKAP-IS" was recently derived from a comprehensive analysis of 10 AKAPs' sequences and bioinformatic design of an optimal RII-binding peptide. This 17-residue peptide binds RII with subnanomolar affinity and disrupts PKA anchoring inside cells (Alto et al. 2003) . The AKAP-IS sequence has also been used as a motif to screen genomes for potential AKAPs.
Although AKAPs were initially thought to interact only with the type II PKA holoenzyme, there is now ample evidence showing that many anchoring proteins also target the type I kinase (Burton et al. 1997; Banky et al. 2000; Herberg et al. 2000) . Two-hybrid screening and affinity purification techniques have identified dualfunction anchoring proteins that can interact with RI or RII and, in a few instances, RI-selective AKAPs have been reported (Angelo and Rubin 1998; Kussel-Andermann et al. 2000; Li et al. 2001) . It would appear that RI anchoring also proceeds through the amphipathic helix, although there may be specific determinants that contribute to the compartmentalization of the type I PKA holoenzyme. In fact, substitution of aliphatic side chains in the hydrophobic face of the Ht31 helix increases af-finity for RI (Miki and Eddy 1999) . In contrast, anchoring proteins such as D-AKAP-1/sAKAP84/149 and D-AKAP-2 exhibit less selectivity for either R subunit and have been designated as dual-function AKAPs (Huang et al. 1997a,b) . Interestingly, recent evidence suggests that a single nucleotide polymorphism (SNP) that is identified in the aging human population causes a valine to isoleucine mutation in the anchoring helix of D-AKAP-2. This mutation increases RI-binding affinity threefold but has no effect on the RII/D-AKAP-2 interaction . In an accompanying paper, those same authors used peptide array technologies to generate a high-affinity binding peptide with a 100-fold preference for RI . Thus it seems likely that reagents will soon be on hand to permit the selective uncoupling of the type I and type II PKA holoenzymes inside cells.
Unique targeting regions
Compartmentalization of PKA-AKAP complexes involves specialized targeting regions on each anchoring protein that participate in protein-lipid or protein-protein interactions. An emerging principle is that proteinlipid interactions target the AKAP/PKA complex to the correct subcellular environment, while additional protein-protein interactions precisely orient the kinase toward its substrates. For example, myristoylation and palmitoylation signals guide the membrane tethering of AKAP15/18 in close proximity of PKA substrates such as calcium channels and sodium channels (Fraser et al. 1998; Gray et al. 1998 ). Yet AKAP15/18 may also be cross-linked to the ␣ 1 subunit of the L-type Ca 2+ channel via a modified leucine zipper motif. Mutation of this targeting sequence on AKAP15/18 prevents kinase anchoring and voltage-dependent potentiation of Ca 2+ channel activity (Hulme et al. 2002) . A parallel mechanism may be in place to precisely orient AKAP15/18 toward neuronal sodium channels, which are also regulated by an anchored pool of PKA. Lipid-binding and protein interaction domains act synergistically to target another anchoring protein, AKAP79/150, to a range of synaptic substrates (Dell'Acqua et al. 1998) . Repeat sequences that bind negatively charged phospholipids orient AKAP79/150 to the inner face of synaptic plasma membranes, whereas this anchoring protein is selectively coupled to distinct substrates such as the AMPAtype glutamate receptor ion channels, calcium channels, or potassium channels through specific protein-protein interactions (Colledge et al. 2000; Dodge and Scott 2000) . The mechanism and functional ramifications of AKAP79/150 targeting are discussed in detail below.
In some cases, targeting of AKAP complexes to substrates only involves protein-protein interactions. MAP2 anchors PKA to microtubules through a C-terminal repeat sequence. Phosphorylation of three PKA sites within each tubulin-binding repeat destabilizes interaction with microtubules (Itoh et al. 1997) . Genetic disruption of the MAP2 gene in mice causes a redistribution of the PKA holoenzyme in neurons that limits certain cAMP-responsive phosphorylation events and causes a reduction in microtubule density and dendritic length (Harada et al. 2002) . One substrate is the L-type calcium channel, which was reported to be present in a macromolecular complex with MAP2, the PKA holoenzyme, and the ␤2-andrenergic receptor (Davare et al. 1999 ). However, cAMP signaling to the L-type calcium channel is maintained in MAP2 knockout mice by compensatory recruitment of anchoring proteins such as AKAP79/150 and AKAP15/18 that also functionally couple to the channel (Gao et al. 1997; Gray et al. 1997) .
There are several instances where multiple AKAPs mediate targeting to the same organelle. Three anchoring proteins (D-AKAP-1/AKAP149, D-AKAP-2, and Rab32) anchor PKA at mitochondria (Huang et al. 1997a (Huang et al. , 1999 Alto et al. 2002) ; two AKAPs (AKAP350-450/CG-NAP and pericentrin) tether the kinase to centrosomes (Schmidt et al. 1999; Diviani et al. 2000) , and Ezrin, WAVE-1, and AKAP-lbc tether PKA to distinct areas of the actin cytoskeleton (Dransfield et al. 1997a; Westphal et al. 2000; Diviani et al. 2001) . Also, an unspecified number of anchoring proteins restrict kinase localization in sperm (Moss and Gerton 2001) . One explanation for these apparent redundancies may be the need to always have a pool of anchored PKA at certain sites. Alternatively, each compartment-specific AKAP may direct the kinase to different subcompartments where specific substrates reside. This latter hypothesis implies that the compartmentalization of PKA could be a more subtle and organized process than was initially appreciated.
Signaling complexes
A most important feature of AKAPs is their ability to interact with several signaling proteins. By simultaneously tethering PKA with enzymes such as protein phosphatases, phosphodiesterases, G proteins, and other protein kinases, these multivalent anchoring proteins coordinate the assembly of signaling complexes that provide focal points for the integration and processing of distinct intracellular signals. The following sections review the role of AKAP signaling complexes in neuronal function.
AKAP79/150
The notion of multivalent anchoring proteins was first proposed for the AKAP79/150 family, a group of three structurally similar orthologs: human AKAP79, murine AKAP150, and bovine AKAP75. The first evidence for a scaffolding function came from a yeast two-hybrid screen using AKAP79 as the bait that isolated clones for the catalytic subunit of the protein phosphatase PP2B (calcineurin; Coghlan et al. 1995) . This finding explained earlier biochemical evidence that PP2B copurified with PKA and an unidentified 75-kD protein from bovine brain extracts (Sarkar et al. 1984) . The PP2B-binding site has now been mapped to a region between residues 315 and 360 of AKAP79, and evidence for the assembly of a PKA-AKAP79-PP2B ternary complex in living cells was provided by fluorescence resonance energy transfer (FRET; Dell'Acqua et al. 2002; Oliveria et al. 2003 ). These experiments demonstrate that PKA and PP2B are precisely targeted to the same intracellular locus. AKAP79/150 also interacts with the catalytic core of most protein kinase C (PKC) isoforms via a site within the first 75 residues of the anchoring protein (Klauck et al. 1996; Faux et al. 1999 ). This provides a mechanism to direct dormant PKC isoforms to postsynaptic membranes. Inhibition of the anchored kinase is relieved by binding of Ca 2+ /calmodulin in a competitive manner, leading to liberation of active PKC at the postsynaptic densities (Faux and Scott 1997) . Thus AKAP79/150 organizes two kinases and a phosphatase that respond to distinct combinations of second messenger signals at synaptic sites (Fig. 2) . Each enzyme participates in the control of distinct phosphorylation events. PP2B opposes the modulation of hippocampal AMPA receptors by anchored PKA . AKAP79/150 has also been implicated in anchoring of PKA and PKC close to the inwardly rectifying potassium channel, Kir2.1 (Dart and Leyland 2001) , the ␤2 adrenergic receptor (Fraser et al. 2000; Cong et al. 2001) , metabotropic glutamate receptors (mGluR5) in perirhinal cortex neurons (Cho et al. 2002) , and GABA receptors at inhibitory synapses (Brandon et al. 2003) .
Although phospholipid-binding domains tether AKAP79/150 to the synaptic membranes, more precise orientation of the signaling complex toward particular substrates is conferred by protein-protein interactions. For example, AKAP79/150 is recruited to heteromeric NMDA receptor clusters through interaction with the membrane-associated guanylyl kinase (MAGUK) PSD-95 (Colledge et al. 2000) . This prototypic synaptic adapter protein contains three PDZ domains, one of which binds to the C-terminal tail of the NMDA receptor, an SH3 domain, and a guanylyl kinase-like domain which interacts with AKAP79/150. Biochemical frac- Figure 2 . AKAP79 scaffold model. Generic illustration of the AKAP79 signaling complex. AKAP79 maintains a signaling scaffold of PKA, PKC, and PP2B, attached to the inner face of the neuron plasma membrane via association with negatively charged phospholipids. More precise orientation of the AKAP79 signaling complex can be mediated by interaction with a membrane-associated guanylyl kinase (MAGUK), which may act as a bridge to link anchored PKA to specific substrates, such as a receptor in the neuron plasma membrane. tionation, co-immunoprecipitation, and immunocytochemical labeling of cultured hippocampal neurons indicate that AKAP150 and PSD-95 are present at a majority of excitatory synapses (Colledge et al. 2000) . In contrast, recruitment of AKAP79/150 to AMPA-type glutamate receptors is mediated via association with another MAGUK protein, SAP97, which acts as a protein bridge to link anchored PKA with a specific substrate, the glutamate receptor subtype GluR1 (Colledge et al. 2000) . This elaborate molecular bridging facilitates the phosphorylation of Ser 845 in the cytoplasmic tail of GluR1, an important regulatory site on the channel that is modified during chemically induced long-term potentiation (LTP; Lee et al. 1998 ). Dephosphorylation of Ser 845 and attenuation of GluR1 channels are mediated by PP2B. In fact, peptide-mediated disruption of PP2B-AKAP79/150 interaction prevents efficient dephosphorylation of the channel and suggests that tight coupling of the phosphatase with its substrate is necessary for modulation of channel activity .
Orientation of the AKAP79/150 signaling complex toward other synaptic substrates is achieved by different binding surfaces on the anchoring protein. The cytoplasmic tail of the KNCQ 2 potassium channel interacts directly with sites in the central portion of AKAP150. This provides a mechanism to precisely orient PKC to sites where it can efficiently phosphorylate Ser 534 and Ser 541 of the channel. Electrophysiological studies have shown that activation of PKC in superior cervical ganglion (SCG) neurons results in the phosphorylation and attenuation of KNCQ 2 channels. The introduction of protein fragments which disrupt the AKAP150-KNCQ 2 channel interaction uncouple this effect, suggesting that an intact macromolecular complex of the channel, anchoring protein, and PKC is required to efficiently attenuate the potassium channel . As the number of AKAP79/150 binding partners increases it is clear that a single anchoring protein can only interact with a subset of these proteins. Thus the postsynaptic environment is likely to contain an array of AKAP79/ 150 signaling complexes with unique compliments of proteins that are engaged in regulation of distinct substrates and molecular events.
WAVE-1
WAVE-1 (also known as Scar-1) is a member of the Wiskott-Aldrich syndrome protein (WASP) family Insall 1998, 1999; Machesky et al. 1999; Rohatgi et al. 1999) . It is a scaffold protein that principally functions to relay signals from the small GTPase Rac to the Arp2/3 complex, a group of seven related proteins that function to nucleate actin polymerization and facilitate dendritic branching of actin filaments (Miki et al. 1998; Robinson et al. 2001 ). The Dictyostelium discoideum ortholog of WAVE-1 was initially discovered in a genetic screen as a supressor of a cyclic-AMP receptor involved in chemotaxis (Scar; Bear et al. 1998 ). Subsequently three mammalian orthologs were cloned (WAVE-1, -2, and -3; Miki et al. 1998; Suetsugu et al. 1999 ). These scaffold proteins act as molecular bridges linking Rho family members to the Arp2/3 complex. WAVE-1 is also a kinase anchoring protein, as it binds PKA and the SH3 domain of the Abelson tyrosine kinase (Abl; Westphal et al. 2000) . Proteomic approaches have identified other binding partners that are positive and negative regulators of WAVE function. Rac promotes WAVE-1 activation by causing the release of an inhibitory complex that includes PIR 121, Nap-125, and HSPC300 (Eden et al. 2002) . In contrast, signaling through Rac is terminated by a WAVE-1-associated GTPase activating (GAP) protein called WRP ( Fig. 3 ; Soderling et al. 2002) . Thus WAVE-1 is capable of recruiting different combinations of signaling enzymes at the neuronal cytoskeleton to control distinct protein phosphorylation and actin remodeling events.
This view is indirectly supported by studies carried out on WAVE-1 "knockout" mice . Although there are clear morphological changes in the brain architecture of WAVE-1 knockout mice, the most intriguing observations are the range of behavioral abnormalities detected. Poor performance in the rotarod, inclined screen, and balance beam tests reflects deficits in sensorimotor function that are often indicative of a perturbed cerebellar physiology . Likewise, a loss of WAVE-1 from regions of the hippocampus and cortex may underlie the learning and memory deficits that were exposed in the Morris water maze. Collectively, these findings define a physiological role for WAVE-1 in the facilitation of behavioral traits that are regulated by a variety of brain regions. Because the role of WAVE proteins is to provide a molecular platform to assemble protein networks, it is reasonable to propose that the removal of a core organizational component such as the scaffolding protein itself is likely to impede the assembly of these molecular machines. Currently it is unclear whether spatial perturbation of some or all of the WAVE-1 binding partners contributes to the aberrant behavioral phenotypes observed in the knockout mice. However, mislocalization of the newly discovered WAVE-1 binding partner WRP may be significant. Happloinsufficiency of WRP has been linked to 3p-syndrome, a severe form of mental retardation in humans with symptoms that include reduced growth, low IQ, atactic gait, and jerky arm movements (Endris et al. 2002) . These symptoms are remarkably similar to the impaired cognitive and sensorimotor functions that were reported for the WAVE-1 knockout mice. WAVE-1 may thus facilitate normal neuronal network connectivity by localizing WRP for its role in the regulation of Rac signaling. Therefore, disruption of actin-based signaling scaffolds that contribute to the formation of synaptic connections may interrupt neuronal responses and be a causative factor in certain disease states. WAVE-1 knockout mice may thus provide an animal model to probe the molecular mechanisms behind cognitive and sensorimotor impairments. Given the number of WAVE-1 binding partners that have been identified to date, it seems likely that the combinatorial assembly of individual signaling networks may provide a mechanism for specifying the assembly and function of filamentous actin structures. The functional importance of the various proteins that interact with WAVE-1 may be investigated by carrying out "knock-in" experiments using specific forms of WAVE-1 where individual protein-binding sites are mutated.
AKAP350/CG-NAP/Yotiao
A number of AKAP complexes arise from the alternative splicing of a single gene on chromosome 7q21 (Fig. 4) . At least four AKAP forms are expressed that are targeted to at least three distinct subcellular locations. Initially, a 120-kD RII-binding fragment was identified and a cDNA encoding a 350-kD protein was isolated from a KE37 human lymphoblastic cell library (Dransfield et al. 1997b; Schmidt et al. 1999) . These findings correlated with the biochemical identification of a high-molecular-weight AKAP that was enriched in centrosomal fractions (Keryer et al. 1993) . Around the same time, variants encoding AKAP450 and CG-NAP were identified by analysis of bacterial artificial chromosomes and yeast two-hybrid analyses, respectively (Takahashi et al. 1999; Witczak et al. 1999 ). The latter protein was named CG-NAP on the basis of its detection in centrosomal and Golgi fractions. Detailed analysis of CG-NAP has identified additional binding partners that include protein phosphatase 2A, the Rhodependent protein kinase PKN, and the protein kinase C epsilon isoform (Takahashi et al. 1999) . Functional studies propose that enzymes in this signaling complex may participate in membrane trafficking, microtubule nucleation, and/or in cell-cycle progression (Takahashi et al. 1999 (Takahashi et al. , 2002 Gillingham and Munro 2000) . Parallel experiments performed on the AKAP450 form suggest that it interacts with the cAMP phosphodiesterase PDE4D3 ). This provides a means to tightly regulate cAMP levels and consequently PKA activity at the centrosome. Interestingly, the compartmentalized PDE4D3 may also influence the activation state of the PKA pool that is tethered at this site through its association with another centrosomal AKAP called pericentrin (Diviani et al. 2000) . Because AKAP450 and pericentrin both contain a C-terminal pericentrin AKAP450 centrin (PAC) domain, it is possible that they interact with the same structural elements at the centrosome (Gillingham and Munro 2000) . This apparent redundancy in PKA anchoring may ensure that the kinase is always anchored to this organelle for an as yet unidentified essential role in some aspect of centrosomal function.
In contrast, yotiao, the shortest splice variant of this family is targeted to submembrane sites where it anchors PKA and protein phosphatase 1 (PP1; Westphal et al. 1999) . Yotiao was identified in a yeast two-hybrid screen for proteins interacting with the C1 exon in the cytoplasmic tail of NR1A subunit of the NMDA receptor (Lin et al. 1998) . Consequently, yotiao regulates channel activity by altering the phosphorylation state of hippocampal NR1A receptors. Favoring NR1A phosphorylation by displacing PP1 from yotiao with a PP1-binding peptide or by inhibiting phosphatase activity with okadaic acid increases NMDA receptor currents, whereas tonic PP1 activity negatively regulates NMDA receptors (Westphal et al. 1999) . This model of channel regulation mediated by yotiao is depicted in Figure 5 . More recently a requirement for yotiao targeting of PKA and PP1 to GABA(A) receptors at inhibitory synapses was demonstrated in the dopaminergic regulation of cognitive processes, and yotiao's interaction with potassium channels was inferred for the control of certain cardiac functions (Wang et al. 2002) . Collectively, the AKAP350/450 CG-NAP/yotiao family are capable of targeting PKA and a plethora of other signaling enzymes (see Fig. 4 ) to a variety of subcellular locations. These complexities are underscored by evidence that individual enzyme-binding sites and organelle targeting domains are encoded by different exons. A more detailed analysis will be required to establish whether each AKAP form transcribed from this gene contains only one targeting domain. Transcriptional regulation is undoubtedly a critical determinant for location and composition of each signaling complex maintained by this gene product.
Conclusions and Perspectives
AKAPs are a diverse family of "signal organizing" proteins that contribute to the precision of intracellular signaling events by directing their anchored enzymes to- ward a subset of their physiological substrates. Historically, the evidence to support their function has been gleaned from analysis of PKA phosphorylation events; however, AKAP-mediated compartmentalization of other signaling enzymes is equally important. For example, AKAP350/CG-NAP, AKAP220, and WAVE-1 assemble functional protein networks that contribute to Rho kinase signaling, glycogen synthase kinase 3 action, and Rac-mediated actin remodeling, respectively (Takahashi et al. 2000; Soderling et al. 2002; Tanji et al. 2002) . Another example is the AKAP79/150-mediated anchoring of PKC␤ for a role in the suppression of M currents in SCG neurons . Undoubtedly, additional cAMP-independent signaling events will be ascribed to AKAP-mediated targeting of enzymes, and functional signaling complexes may be formed that do not involve PKA.
One important property of AKAPs is to compartmentalize signal termination enzymes. This is exemplified by yotiao, AKAP220, and AKAP149, which tether protein phosphatase 1 to oppose the action of anchored kinase counterparts (Schillace and Scott 1999; Westphal et al. 1999; Steen et al. 2000) . This creates an environment where protein phosphorylation is only favored when kinase activity is sufficiently stimulated to overcome these basal dephosphorylation events. Another variation on this theme occurs where anchored signal termination enzymes act upstream of protein phosphorylation events. For example, AKAP450 and mAKAP colocalize a cAMP-metabolizing enzyme PDE4D3 with a cAMP-dependent protein kinase such that anchored phosphodiesterase reduces cAMP levels in the vicinity of the kinase (Dodge et al. 2001; Tasken et al. 2001 ). These signaling complexes not only contribute to the formation of intracellular gradients of cAMP but also contribute to the spatial and temporal resolution of PKA signaling by generating pulses of kinase activity.
In conclusion, it seems appropriate to speculate on some emerging aspects of AKAP research. These include detailed proteomic dissection of AKAP complexes (Eden et al. 2002; Soderling et al. 2002) , the identification of distinct determinants on the AKAPs that confer type I or type II PKA anchoring (Alto et al. 2003 ) and the detection of genetic polymorphisms in D-AKAP2 that may correlate with cardiovascular signaling defects in the aging population . Particular mention should be given to behavioral and electrophysiological studies that have implicated AKAP complexes in the control of neural processes that underlie different forms of learning and memory. Displacement of PKA from AKAPs in the lateral amygdala depresses auditory fear conditioning in rats, whereas treatment of hippocampal slices with anchoring inhibitor peptides occludes synaptically induced long-term depression (LTD; Moita et al. 2002; E.M. Snyder, M. Colledge, R.A. Crozier, J.D. Scott, and M.F. Bear, in prep.) . AKAP79/150 has been implicated in the modulation of both neuronal behaviors, although more definitive analyses are necessary to confirm this notion. PKA anchoring may also contribute to the surface expression of AMPA channels by orchestrating signaling events that promote AMPA receptor endocytosis. On the basis of their postsynaptic location, AKAP79/ 150 and yotiao seem reasonable candidates to fulfill this function, although another possibility is neurobeachin, a recently identified postsynaptic AKAP that contains a BEACH-WD40 domain (Wang et al. 2000) . This protein is believed to interact with the protein sorting machinery, including endosomes, lysosomes, and the plasma membrane (Nagle et al. 1996) . Thus regulation of AMPA receptor trafficking may involve several AKAP networks that coordinate signaling at different phases of the endocytic pathway. Finally, exhaustive database searches have traced the conservation of certain AKAPs from Caenorhabditis elegans and Drosophila melanogaster to mammals. Perhaps the most intriguing findings come from analysis of the Zebrafish genome, where WAVE-1, mAKAP, AKAP79, and AKAP18 orthologs have been identified with surprisingly high homology to their mammalian counterparts. Characterization and genetic manipulation of these putative AKAPs may provide a means to study the role of PKA anchoring in neural development.
